Your search for bevacizumab returned 15 results

Increased recurrence-free survival seen for patients with high-risk HCC following resection or ablation.

At the end of one year, likelihood of being weaned off treatment was higher for eyes treated with aflibercept versus bevacizumab

Alymsys is a vascular endothelial growth factor inhibitor.

Vegzelma is a vascular endothelial growth factor inhibitor.

Outcomes at 2 years comparable among patients with diabetic macular edema receiving aflibercept monotherapy, bevacizumab first

Researchers investigated the association between nonalcoholic fatty liver disease and early-onset colorectal cancer according to anatomical site.

Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.

Bevacizumab-adcd 100mg, 400mg; per vial; soln for IV infusion after dilution; preservative-free.

Bevacizumab-bvzr 100mg, 400mg; per vial; soln for IV infusion after dilution; preservative-free.

High drug prices and ongoing shortages may prompt cancer patients to buy treatments online and fall prey to illegitimate pharmacies.